Outset Medical OM 深 沪
已收盘 10-23 16:00:00 美东时间
4.10
-0.070
-1.68%
华盛通- 最 高4.175
- 今 开4.12
- 成交量 3.83万股
- 最 低 4.07
- 昨 收 4.17
- 总市值 7706.84万
- 52周最高 13.285
- 市盈率 静 --
- 换手率 0.20%
- 52周最低 2.8405
- 委 比 -1.92%
- 总股本 1879.72万
- 历史最高 978.45
- 量 比 0.29
- 振 幅 2.52%
- 历史最低 2.8405
- 每 手 1
- 风险率 2.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Outset Medical announced it will release its Q3 2026 financial results on November 4, 2026, after market close. On the same day at 1:30 p.m. PT (4:30 p.m. ET), Leslie Trigg, CEO, and Renee Gaeta, CFO, will host a conference call to discuss the results. Interested parties can access the live or archived call via the "Investors" section on Outset Medical's website or register via the provided link to join by phone. Outset Medical, a medical technol...
10-21 20:05
Full Transcript: Outset Medical Q2 2026 Earnings Call
Outset Medical (NASDAQ:OM) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. Vie...
10-12 17:25
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
Alamar Biosciences announced the addition of Bob Ragusa to its board of directors, bringing over two decades of leadership in genomics, diagnostics, and biotech. The company also appointed John Brottem as general counsel and Amelia Merrill as chief people officer. Alamar's NULISA platform enables ultra-sensitive protein biomarker detection, advancing disease early detection.
10-05 20:05
电话会总结 ｜ Outset Medical(OM)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Outset Medical业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 2025年全年营收1.195亿美元，同比增长5% - Q4营收2,890万美元，其中产品营收1,990万美元，服务及其他营收900万美元 - 产品营收细分：控制台销售640万美元（同比增长11%），耗材销售1,350万美元 - 服务及其他营收900万美元，同比增长6%（上年同期850万美元） - 经常性营收全年8,870万美元，同比增长6%；Q4经常性营收2,250万美元 **利润率表现：** - 全年非GAAP毛利率39.6%，同比提
05-10 12:14
Outset Medical shares are trading lower after the company reported worse-than-expected Q1 financial results.
Outset Medical shares are trading lower after the company reported worse-than-e...
05-08 22:57
Outset Medical Q1 Adj. EPS $(0.83) Misses $(0.79) Estimate, Sales $27.863M Miss $28.900M Estimate
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.79) by 5.06 percent. This is a 74.38 percent increase over losses of $(3.24) per share from the
05-08 04:09
EXCLUSIVE: 'Options Premium Is The Engine,' Says CEO As VistaShares Crosses $1 Billion AUM
VistaShares tops $1B AUM as its AI ETF gains 60%, beating the Nasdaq-100, while its income strategy targets a 15% yield, says CEO Adam Patti.
04-17 23:28
What's Going On With Occidental Petroleum Stock Thursday?
OXY shares trade higher as escalating geopolitical tensions and rising crude prices push investors toward high-performing energy stocks.
04-02 23:07
美股大行评级 | AppLovin评级分歧大！高盛等4家下调，韦德布什上调；HubSpot、休曼纳公司、Shopify、Unity、Paycom Software等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从39美元升至47美元；HC Wainwright & Co.：维持Agios制药"买入"评级，目标价从62美元升至65美元
02-13 15:30
BTIG Maintains Buy on Outset Medical, Lowers Price Target to $15
BTIG analyst Marie Thibault maintains Outset Medical (NASDAQ:OM) with a Buy and lowers the price target from $17 to $15.
02-12 18:01
